Friday, December 02, 2016 4:12:40 PM
The USPTO just confirmed that all 3 patents are still invalidated. MNTA had a quick spike and then dropped off. No change for TEVA stock either.
I think both stocks go up from here. TEVA is down from $70 to $36. It is crazy that the market thinks Teva is going to lose all of its Copaxone sales (if not, why has the stock been cut in half) and yet thinks MNTA / NVS will sell none of the 40 mg Copaxone. Otherwise, how do you explain the lack of price movement in MNTA (or NVS for that matter)?
http://seekingalpha.com/news/3228370-teva-loses-bid-revive-413-copaxone-patent-bloomberg
PS: MYL, TEVA, NVS, AZN all at 52 week lows. Anybody thinking of these stocks now?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM